FOXO proteins are a conserved family of transcription factors that regulate metabolism, stress responses, and lifespan. Loss of FOXO proteins is associated with cancer, neurodegenerative and metabolic diseases. Insulin/IGF signaling (IIS) pathway negatively regulate FOXO by activating the Akt1/2 kinase, which phosphorylates FOXO. The 14-3-3 proteins bind phospho-FOXO (pFOXO), sequestering it in the cytoplasm. FOXO proteins were first identified as downstream targets of IIS in the nematode C. elegans which has a single FOXO, DAF-16, that is most closely related to human FOXO3a. During fed conditions, C. elegans IIS is constitutive which keeps DAF-16 in the cytoplasm. Under starvation conditions (and other stresses), there is no IIS, and DAF-16 enters the nucleus to regulate gene expression. We found that in the intestine of fed C. elegans, DAF-16 localizes to a subset of RAB-5-positive early endosomes. DAF-16 endosomes are lost in
rab-5(RNAi) animals and significantly expanded in
tbc-2 mutants that result in increased RAB-5 activity. In starved animals, DAF-16 endosomes are lost, and DAF-16 localizes mainly to the nucleus, whereas re-feeding results in relocalization of DAF-16 onto endosomal membranes. These results suggest that IIS promotes DAF-16 localization to endosomes. Consistent with this hypothesis, loss of
daf-18 pten, a negative regulator of IIS, results in an increase in the number of animals with DAF-16 endosomes, while knockdown of the 14-3-3 protein, FTT-2, results in loss of DAF-16 endosomes. Furthermore, we found that FTT-2 14-3-3 protein colocalizes with DAF-16 on endosomes. This suggests that the endosomal pool of DAF-16 is phosphorylated. This is conserved in human cells as we discovered that pFOXO1/3a colocalizes with activated Rab5 on the endosomes in HEK293 cells. We do not know the ultimate fate of pFOXO on endosomes, but our data shows that LGG-1 engulfs DAF-16 endosomes and knockdown of
lgg-1/2 increased the number of DAF-16 endosomes, suggesting that they are degraded by autophagy. We hypothesize that IIS pathway regulates FOXO proteins on endosomes where it can be released if needed or degraded via selective autophagy. Relevance: Here we are proposing a new mechanism of FOXO regulation on signaling endosomes and turnover by selective autophagy. We believe this project will provide new insights into the regulation of FOXO proteins and open new avenues for drug development to regulate FOXO in cancer, neurodegenerative and metabolic diseases.